Search research articles
Contact Us
Filters
Showing results (51-60 of 277) with videos related to
Page
of 28
Sort By:
Annals of Surgical Oncology
|
January 15, 2025
Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205)
Masayuki Shinkai, Motohiro Imano, Masaki Yokokawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 7, 2018
Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study
Kensei Yamaguchi, Kazumasa Fujitani, Fumio Nagashima, et al.
International Journal of Oncology
|
January 19, 2018
The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells
Kosuke Taketo, Masamitsu Konno, Ayumu Asai, et al.
Medical Oncology (Northwood, London, England)
|
December 19, 2024
Phase I study of neoadjuvant chemoradiotherapy with S-1 for clinically resectable type 4 or large type 3 gastric cancer in elderly patients aged 75 years and older (OGSG1303)
Masayuki Shinkai, Motohiro Imano, Masaki Yokokawa, et al.
International Journal of Molecular Sciences
|
April 17, 2025
In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines
Sikun Meng, Tomoaki Hara, Yutaka Miura, et al.
Cancer Science
|
February 26, 2019
Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance
Yuji Takaoka, Masamitsu Konno, Jun Koseki, et al.
Annals of Surgical Oncology
|
August 28, 2019
Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer
Takaomi Hagi, Tomoki Makino, Makoto Yamasaki, et al.
Oncology Letters
|
June 29, 2012
Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study
Takenori Takahata, Jugoh Itoh, Taroh Satoh, et al.
Scientific Reports
|
July 4, 2023
Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection
Chihiro Sato, Hisato Kawakami, Ryo Tanaka, et al.
World Journal of Gastrointestinal Oncology
|
September 28, 2019
Gallbladder cancer harboring <i>ERBB2</i> mutation on the primary and metastatic site: A case report
Chiaki Inagaki, Daichi Maeda, Akie Kimura, et al.
Page
of 28
Search research articles
Search
Showing results (51-60 of 277) with videos related to
Sort By:
Page
of 28
Annals of Surgical Oncology
|
January 15, 2025
Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205)
Masayuki Shinkai, Motohiro Imano, Masaki Yokokawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 7, 2018
Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study
Kensei Yamaguchi, Kazumasa Fujitani, Fumio Nagashima, et al.
International Journal of Oncology
|
January 19, 2018
The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells
Kosuke Taketo, Masamitsu Konno, Ayumu Asai, et al.
Medical Oncology (Northwood, London, England)
|
December 19, 2024
Phase I study of neoadjuvant chemoradiotherapy with S-1 for clinically resectable type 4 or large type 3 gastric cancer in elderly patients aged 75 years and older (OGSG1303)
Masayuki Shinkai, Motohiro Imano, Masaki Yokokawa, et al.
International Journal of Molecular Sciences
|
April 17, 2025
In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines
Sikun Meng, Tomoaki Hara, Yutaka Miura, et al.
Cancer Science
|
February 26, 2019
Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance
Yuji Takaoka, Masamitsu Konno, Jun Koseki, et al.
Annals of Surgical Oncology
|
August 28, 2019
Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer
Takaomi Hagi, Tomoki Makino, Makoto Yamasaki, et al.
Oncology Letters
|
June 29, 2012
Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study
Takenori Takahata, Jugoh Itoh, Taroh Satoh, et al.
Scientific Reports
|
July 4, 2023
Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection
Chihiro Sato, Hisato Kawakami, Ryo Tanaka, et al.
World Journal of Gastrointestinal Oncology
|
September 28, 2019
Gallbladder cancer harboring <i>ERBB2</i> mutation on the primary and metastatic site: A case report
Chiaki Inagaki, Daichi Maeda, Akie Kimura, et al.
Page
of 28